Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover

The Journal of Pediatrics

Volumn 113, Issue 2, 1988, Pages 387-392

  Uauy, Ricardo ^a   Vega, Gloria Lena ^a   Grundy, Scott M ^a   Bilheimer, David M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CASE REPORT; DRUG EFFICACY; FAMILIAL HYPERCHOLESTEROLEMIA; HEREDITY; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; SCHOOL CHILD;

APOLIPOPROTEINS B; CHILD; CHOLESTEROL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA, FAMILIAL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LOVASTATIN; MALE; RECEPTORS, LDL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023772380     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(88)80289-0     Document Type: Article

References (24)

1. Familial hypercholesterolemia
2. Competitive inhibition of 3-hydroxy-3methyl-glutaryl coenzyme: A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity
3. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes
4. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog
5. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia
6. The Lebanese allele at the low density lipoprotein receptor locus
7. Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patient with coronary heart disease
8. Enzymatic determination of total cholesterol in serum
9. Triglycerides determination after enzymatic hydrolysis
10. Lipid Research Clinics Program manual of laboratory operations
11. Protocol for efficient plasma sampling for low density lipoprotein turnover studies
12. Metabolic studies in familial hypercholesterolemia: Evidence for a gene-dosage effect in vivo
13. Therapeutic effects of ML-236B in primary hypercholesterolemia
14. Efficacy of mevinolin and adjuvant therapy for refractory familial hypercholesterolemia
15. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway
16. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia
17. Defective lipoprotein receptors and atherosclerosis: Lessons from an animal counterpart of familial hypercholesterolemia
18. Simultaneous measurement of apolipoprotein B turnover in very low and low-density lipoproteins in familial hypercholesterolemia
19. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma lipoproteins VLDL, IDL, and LDL
20. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL, an animal model of familial hypercholesterolemia
21. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion of low density lipoproteins in WHHL rabbits
22. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits
23. Enhanced binding by cultured human fibroblasts of apo-E containing lipoproteins as compared with low density lipoproteins
24. Suppression of apolipoprotein B production during treatment of cholesterol ester storage disease with lovastatin. Implications for regulation of apolipoprotein B